RadNet, Inc. (RDNT)
USD 49.01
(1.72%)
USD 49.01
(1.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.88 Billion USD | 18.6% |
| 2022 | 2.43 Billion USD | 18.24% |
| 2021 | 2.05 Billion USD | 15.21% |
| 2020 | 1.78 Billion USD | 8.57% |
| 2019 | 1.64 Billion USD | 48.34% |
| 2018 | 1.1 Billion USD | 27.66% |
| 2017 | 868.97 Million USD | 2.3% |
| 2016 | 849.47 Million USD | 1.32% |
| 2015 | 838.43 Million USD | 13.2% |
| 2014 | 740.68 Million USD | 2.51% |
| 2013 | 722.57 Million USD | 1.04% |
| 2012 | 715.11 Million USD | 15.49% |
| 2011 | 619.18 Million USD | 14.77% |
| 2010 | 539.51 Million USD | 12.24% |
| 2009 | 480.67 Million USD | -3.01% |
| 2008 | 495.57 Million USD | 14.29% |
| 2007 | 433.62 Million USD | 230.09% |
| 2006 | 131.36 Million USD | 8.36% |
| 2005 | 121.23 Million USD | -4.88% |
| 2004 | 127.45 Million USD | -10.27% |
| 2003 | 142.03 Million USD | -6.33% |
| 2002 | 151.63 Million USD | 18.07% |
| 2001 | 128.42 Million USD | 41.71% |
| 2000 | 90.62 Million USD | 25.52% |
| 1999 | 72.2 Million USD | 15.23% |
| 1998 | 62.65 Million USD | -27.43% |
| 1997 | 86.33 Million USD | -18.49% |
| 1996 | 105.93 Million USD | 58.68% |
| 1995 | 66.75 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.96 Billion USD | 2.87% |
| 2024 Q2 | 3.22 Billion USD | 8.75% |
| 2023 Q1 | 2.41 Billion USD | -0.82% |
| 2023 FY | 2.88 Billion USD | 18.6% |
| 2023 Q4 | 2.88 Billion USD | 7.39% |
| 2023 Q2 | 2.7 Billion USD | 12.06% |
| 2023 Q3 | 2.68 Billion USD | -0.64% |
| 2022 Q4 | 2.43 Billion USD | 8.31% |
| 2022 FY | 2.43 Billion USD | 18.24% |
| 2022 Q3 | 2.24 Billion USD | 0.29% |
| 2022 Q2 | 2.24 Billion USD | 4.63% |
| 2022 Q1 | 2.14 Billion USD | 4.03% |
| 2021 FY | 2.05 Billion USD | 15.21% |
| 2021 Q4 | 2.05 Billion USD | 0.79% |
| 2021 Q3 | 2.04 Billion USD | 0.5% |
| 2021 Q1 | 1.82 Billion USD | 2.36% |
| 2021 Q2 | 2.03 Billion USD | 11.12% |
| 2020 Q2 | 1.71 Billion USD | 1.04% |
| 2020 FY | 1.78 Billion USD | 8.57% |
| 2020 Q1 | 1.69 Billion USD | 3.27% |
| 2020 Q4 | 1.78 Billion USD | 4.0% |
| 2020 Q3 | 1.71 Billion USD | 0.05% |
| 2019 Q1 | 1.52 Billion USD | 37.57% |
| 2019 FY | 1.64 Billion USD | 48.34% |
| 2019 Q2 | 1.59 Billion USD | 4.63% |
| 2019 Q3 | 1.61 Billion USD | 1.33% |
| 2019 Q4 | 1.64 Billion USD | 1.71% |
| 2018 Q4 | 1.1 Billion USD | 21.82% |
| 2018 FY | 1.1 Billion USD | 27.66% |
| 2018 Q1 | 923.62 Million USD | 6.29% |
| 2018 Q2 | 912.98 Million USD | -1.15% |
| 2018 Q3 | 910.64 Million USD | -0.26% |
| 2017 FY | 868.97 Million USD | 2.3% |
| 2017 Q4 | 868.97 Million USD | 2.48% |
| 2017 Q3 | 847.91 Million USD | -0.46% |
| 2017 Q2 | 851.82 Million USD | -0.25% |
| 2017 Q1 | 853.98 Million USD | 0.53% |
| 2016 Q3 | 843.39 Million USD | 1.82% |
| 2016 Q4 | 849.47 Million USD | 0.72% |
| 2016 Q2 | 828.34 Million USD | -2.05% |
| 2016 Q1 | 845.71 Million USD | 0.87% |
| 2016 FY | 849.47 Million USD | 1.32% |
| 2015 Q1 | 742.4 Million USD | 0.23% |
| 2015 Q2 | 788.5 Million USD | 6.21% |
| 2015 Q4 | 838.43 Million USD | 3.65% |
| 2015 FY | 838.43 Million USD | 13.2% |
| 2015 Q3 | 808.87 Million USD | 2.58% |
| 2014 Q3 | 748.51 Million USD | 1.36% |
| 2014 FY | 740.68 Million USD | 2.51% |
| 2014 Q4 | 740.68 Million USD | -1.05% |
| 2014 Q2 | 738.44 Million USD | 0.16% |
| 2014 Q1 | 737.24 Million USD | 2.03% |
| 2013 Q2 | 726.73 Million USD | -0.06% |
| 2013 Q4 | 722.57 Million USD | 1.04% |
| 2013 FY | 722.57 Million USD | 1.04% |
| 2013 Q1 | 727.13 Million USD | 1.68% |
| 2013 Q3 | 715.13 Million USD | -1.6% |
| 2012 FY | 715.11 Million USD | 15.49% |
| 2012 Q3 | 625 Million USD | -0.41% |
| 2012 Q2 | 627.6 Million USD | 0.21% |
| 2012 Q1 | 626.28 Million USD | 1.15% |
| 2012 Q4 | 715.11 Million USD | 14.42% |
| 2011 Q1 | 556.58 Million USD | 3.16% |
| 2011 Q3 | 572.23 Million USD | 0.2% |
| 2011 FY | 619.18 Million USD | 14.77% |
| 2011 Q4 | 619.18 Million USD | 8.21% |
| 2011 Q2 | 571.07 Million USD | 2.6% |
| 2010 Q2 | 529 Million USD | 12.39% |
| 2010 Q3 | 537.65 Million USD | 1.64% |
| 2010 FY | 539.51 Million USD | 12.24% |
| 2010 Q4 | 539.51 Million USD | 0.35% |
| 2010 Q1 | 470.67 Million USD | -2.08% |
| 2009 Q3 | 476.16 Million USD | -1.27% |
| 2009 Q4 | 480.67 Million USD | 0.95% |
| 2009 Q1 | 491.82 Million USD | -0.76% |
| 2009 Q2 | 482.28 Million USD | -1.94% |
| 2009 FY | 480.67 Million USD | -3.01% |
| 2008 Q2 | 509.82 Million USD | 2.39% |
| 2008 FY | 495.57 Million USD | 14.29% |
| 2008 Q3 | 517.62 Million USD | 1.53% |
| 2008 Q4 | 495.57 Million USD | -4.26% |
| 2008 Q1 | 497.92 Million USD | 14.83% |
| 2007 Q2 | 393.35 Million USD | -0.74% |
| 2007 Q1 | 396.27 Million USD | 0.0% |
| 2007 Q3 | 433.96 Million USD | 10.32% |
| 2007 Q4 | 433.62 Million USD | -0.08% |
| 2007 FY | 433.62 Million USD | 230.09% |
| 2006 Q3 | 131.36 Million USD | 3.76% |
| 2006 FY | 131.36 Million USD | 8.36% |
| 2006 Q2 | 126.6 Million USD | 2.94% |
| 2006 Q1 | 122.97 Million USD | 3.71% |
| 2005 Q3 | 121.23 Million USD | -1.08% |
| 2005 FY | 121.23 Million USD | -4.88% |
| 2005 Q4 | 118.58 Million USD | -2.18% |
| 2005 Q2 | 122.56 Million USD | -2.25% |
| 2005 Q1 | 125.37 Million USD | -0.22% |
| 2004 Q4 | 125.64 Million USD | -1.41% |
| 2004 Q1 | 140.2 Million USD | -2.26% |
| 2004 Q3 | 127.45 Million USD | -6.15% |
| 2004 Q2 | 135.8 Million USD | -3.14% |
| 2004 FY | 127.45 Million USD | -10.27% |
| 2003 Q2 | 145.81 Million USD | -3.22% |
| 2003 FY | 142.03 Million USD | -6.33% |
| 2003 Q3 | 142.03 Million USD | -2.59% |
| 2003 Q1 | 150.66 Million USD | -2.57% |
| 2003 Q4 | 143.44 Million USD | 0.99% |
| 2002 FY | 151.63 Million USD | 18.07% |
| 2002 Q4 | 154.63 Million USD | 1.98% |
| 2002 Q3 | 151.63 Million USD | 0.03% |
| 2002 Q2 | 151.59 Million USD | 3.09% |
| 2002 Q1 | 147.04 Million USD | 5.52% |
| 2001 Q1 | 95.8 Million USD | 4.88% |
| 2001 FY | 128.42 Million USD | 41.71% |
| 2001 Q4 | 139.35 Million USD | 8.5% |
| 2001 Q3 | 128.42 Million USD | 16.17% |
| 2001 Q2 | 110.54 Million USD | 15.39% |
| 2000 Q1 | 76.92 Million USD | 1.35% |
| 2000 Q4 | 91.35 Million USD | 0.8% |
| 2000 Q3 | 90.62 Million USD | 5.39% |
| 2000 Q2 | 85.98 Million USD | 11.79% |
| 2000 FY | 90.62 Million USD | 25.52% |
| 1999 Q1 | 68.1 Million USD | -0.15% |
| 1999 Q4 | 75.9 Million USD | 5.12% |
| 1999 FY | 72.2 Million USD | 15.23% |
| 1999 Q3 | 72.2 Million USD | 6.33% |
| 1999 Q2 | 67.9 Million USD | -0.29% |
| 1998 FY | 62.65 Million USD | -27.43% |
| 1998 Q3 | 62.7 Million USD | -24.37% |
| 1998 Q2 | 82.9 Million USD | -0.48% |
| 1998 Q1 | 83.3 Million USD | -0.48% |
| 1998 Q4 | 68.2 Million USD | 8.77% |
| 1997 Q1 | 86.9 Million USD | -13.53% |
| 1997 FY | 86.33 Million USD | -18.49% |
| 1997 Q4 | 83.7 Million USD | -3.01% |
| 1997 Q2 | 89.1 Million USD | 2.53% |
| 1997 Q3 | 86.3 Million USD | -3.14% |
| 1996 Q4 | 100.5 Million USD | -5.1% |
| 1996 Q3 | 105.9 Million USD | 47.29% |
| 1996 FY | 105.93 Million USD | 58.68% |
| 1996 Q2 | 71.9 Million USD | -0.55% |
| 1996 Q1 | 72.3 Million USD | 0.0% |
| 1995 FY | 66.75 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aspira Women's Health Inc. | 6.26 Million USD | -45998.579% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -35011.29% |
| Biodesix, Inc. | 99.09 Million USD | -2813.027% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 11.449% |
| Illumina, Inc. | 10.11 Billion USD | 71.45% |
| Standard BioTools Inc. | 323.06 Million USD | -793.528% |
| 23andMe Holding Co. | 395.16 Million USD | -630.5% |
| NeoGenomics, Inc. | 1.68 Billion USD | -71.701% |
| Neogen Corporation | 4.58 Billion USD | 37.029% |
| Inotiv, Inc. | 856.53 Million USD | -237.022% |
| Psychemedics Corporation | 13.27 Million USD | -21653.527% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -3219.03% |
| T2 Biosystems, Inc. | 34.79 Million USD | -8195.81% |
| Castle Biosciences, Inc. | 477.81 Million USD | -504.15% |
| Exact Sciences Corporation | 6.47 Billion USD | 55.393% |
| Prenetics Global Limited | 254.17 Million USD | -1035.731% |
| iSpecimen Inc. | 15.81 Million USD | -18148.107% |
| OpGen, Inc. | 1.88 Million USD | -153261.997% |
| Neuronetics, Inc. | 115.83 Million USD | -2392.159% |
| Precipio, Inc. | 18.1 Million USD | -15847.699% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -20850.154% |
| Exagen Inc. | 56.94 Million USD | -4969.354% |
| Bionano Genomics, Inc. | 214.4 Million USD | -1246.38% |
| CareDx, Inc | 484.61 Million USD | -495.667% |
| Check-Cap Ltd. | 25.01 Million USD | -11438.926% |
| Twist Bioscience Corporation | 776.4 Million USD | -271.803% |
| Guardant Health, Inc. | 1.78 Billion USD | -61.591% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -25222.328% |
| Natera, Inc. | 1.45 Billion USD | -98.109% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | -126.744% |
| Sera Prognostics, Inc. | 95.44 Million USD | -2924.584% |
| OPKO Health, Inc. | 2.01 Billion USD | -43.495% |
| Personalis, Inc. | 225.09 Million USD | -1182.41% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -1362.32% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -21045.491% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -140.819% |
| ICON Public Limited Company | 16.98 Billion USD | 83.009% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -3219.03% |
| MDxHealth SA | 129.13 Million USD | -2135.459% |
| Prenetics Global Limited | 254.17 Million USD | -1035.731% |
| DarioHealth Corp. | 96.38 Million USD | -2894.837% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -42639.571% |
| Medpace Holdings, Inc. | 1.65 Billion USD | -74.23% |
| Mainz Biomed B.V. | 15.4 Million USD | -18633.777% |
| Trinity Biotech plc | 59.43 Million USD | -4756.891% |
| Sotera Health Company | 3.13 Billion USD | 7.786% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -35011.29% |